Led by David Liljenquist, MD, the TrialNet team at Rocky Mountain Diabetes and Osteoporosis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Rocky Mountain Diabetes and Osteoporosis Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Led by Rashmi Jain, MD., the TrialNet team at Sanford Children's Specialty Clinic is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Luis Casas, MD, the TrialNet team at Sanford Health is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Sanford Health is regionally overseen by University of Minnesota. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Athena Philis-Tsimikas, MD, the TrialNet team at Scripps Whittier Diabetes Institute is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Scripps Whittier Diabetes Institute is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution.

Led by Catherine Pihoker, MD, the TrialNet team at Seattle Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Seattle Children's Hospital is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Daniel Flynn, MD, the TrialNet team at St. Lukes Humphreys Diabetes Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, St. Lukes Humphreys Diabetes Center is regionally overseen by Benaroya Research Institute. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Stanford University is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.   

Led by Maria Contreras, MD, the TrialNet team at Texas Tech University Health Sciences Center at Amarillo is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Texas Tech University Health Sciences Center is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The Hospital for Sick Children (SickKids) is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Led by David Sparling, MD, PhD, the TrialNet team at University of Oklahoma Health Sciences Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Oklahoma Health Sciences Center is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution.